| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/23/1998 | CA2268897A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268895A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268894A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268103A1 Sulfonamide substituted aspartic acid interleukin-1.beta. converting enzyme inhibitors |
| 04/23/1998 | CA2268086A1 Sulfonamide interleukin-1.beta. converting enzyme inhibitors |
| 04/23/1998 | CA2266889A1 Purine l-nucleosides, analogs and uses thereof |
| 04/22/1998 | EP0836621A1 Novel human g-protein coupled receptor |
| 04/22/1998 | CN1179774A Arginine analogues having nitric oxide synthase inhibitor activity |
| 04/22/1998 | CN1179418A Novel cyloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/22/1998 | CN1179315A Medicine for treating hyperosteogeny disease and preparing process thereof |
| 04/21/1998 | US5741810 Prostaglandins for ocular hypotension for treatment of glaucoma |
| 04/21/1998 | US5741796 Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated bone resorption |
| 04/16/1998 | WO1998015568A2 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 04/16/1998 | WO1998015278A1 Method for stimulating bone formation |
| 04/15/1998 | EP0835868A1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods |
| 04/15/1998 | CN1178697A Chinese drug for curing rheumatism and its producing technology |
| 04/14/1998 | US5739138 Modulators of cellular response |
| 04/14/1998 | CA2015473C Triphenylmethane derivatives |
| 04/10/1998 | CA2217810A1 2-aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods |
| 04/09/1998 | WO1998014596A2 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | WO1998014582A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | WO1998014424A1 Hydroxamic acid derivatives |
| 04/09/1998 | WO1998014222A1 Methods and compositions for programming an organic matrix for remodeling into a target tissue |
| 04/09/1998 | WO1998014196A1 Liquid alendronate formulations |
| 04/09/1998 | WO1998014195A1 Use of vitamin d analogs for the treatment of arthritic disease |
| 04/09/1998 | WO1998014192A1 Vitronectin receptor antagonists |
| 04/09/1998 | CA2267415A1 Hydroxamic acid derivatives |
| 04/09/1998 | CA2267370A1 Liquid alendronate formulations |
| 04/09/1998 | CA2267193A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | CA2267111A1 Methods and compositions for programming an organic matrix for remodeling into a target tissue |
| 04/09/1998 | CA2265449A1 Disease associated protein tyrosine phosphatases |
| 04/08/1998 | EP0834563A2 Human 7-transmembrane receptor, member of the chemokine receptor family, named Strl-33 |
| 04/08/1998 | EP0833651A1 ANALGESIC USE OF N-L-$g(a)-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER |
| 04/08/1998 | EP0833643A1 Anhydrous alendronate monosodium salt formulations |
| 04/08/1998 | EP0833626A1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders |
| 04/08/1998 | CN1178467A Polyphenol fractions of tea, the use thereof and formulations containing same |
| 04/07/1998 | US5736507 Peptide of human cartilage glycoprotein 39, which stimulates autoreactive t-cells found in blood of rheumatoid arthritis patients |
| 04/07/1998 | US5736381 An isolated and purified polynucleotide sequence encoding a polypeptide containing specific amino acid sequence |
| 04/07/1998 | US5735903 Meniscal augmentation device |
| 04/02/1998 | WO1998013509A1 Novel morphogen-responsive signal transducer and methods of use thereof |
| 04/02/1998 | WO1998013376A1 Inhibitors of pla¿2? |
| 04/02/1998 | WO1998013369A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 04/02/1998 | WO1998013354A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 04/02/1998 | WO1998013062A1 Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression |
| 04/02/1998 | CA2267666A1 Novel morphogen-responsive signal transducer and methods of use thereof |
| 04/02/1998 | CA2266746A1 Inhibitors of pla2 |
| 04/02/1998 | CA2266098A1 Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression |
| 04/02/1998 | CA2265950A1 Spiro-azacyclic derivatives and their use as therapeutic agents |
| 04/01/1998 | EP0832891A1 Dihydrobenzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods |
| 04/01/1998 | EP0832890A1 Benzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods |
| 04/01/1998 | EP0832888A1 Benzothiophene compounds, compositions, and methods |
| 04/01/1998 | EP0832883A1 Tetrahydrobenzo(a)fluorene compounds and methods of use |
| 04/01/1998 | EP0832882A2 Naphthofluorene compounds, intermediates, compositions, and methods |
| 04/01/1998 | EP0832881A2 Benzofluorene compounds, intermediates, compositions, and methods |
| 04/01/1998 | EP0832880A1 Dihydrobenzofluorene compounds, intermediates, compositions, and methods |
| 04/01/1998 | EP0832221A1 Bone stimulating factor |
| 04/01/1998 | EP0832082A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 04/01/1998 | EP0832076A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 04/01/1998 | EP0831884A1 Methods and compositions for healing and repair of connective tissue attachment |
| 04/01/1998 | EP0831830A1 Imidazole compounds |
| 04/01/1998 | EP0831808A1 Osteogenetic promoting pharmaceutical composition |
| 04/01/1998 | EP0831789A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
| 04/01/1998 | CN1177927A Extracts of shark cartilage, process of production and uses thereof |
| 04/01/1998 | CN1177483A Fracture-setting capsule of promoting blood-circulation and causing muscles and joints to relax |
| 03/31/1998 | US5733897 Imidobisphosphoric acids, and use therefor |
| 03/31/1998 | US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 03/27/1998 | CA2214922A1 Benzothiophene compounds, compositions, and methods |
| 03/26/1998 | WO1998012322A1 Bone morphogenetic protein-16 (bmp-16) compositions |
| 03/26/1998 | WO1998012221A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases |
| 03/26/1998 | WO1998012211A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 03/26/1998 | WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 03/26/1998 | WO1998012177A1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 03/26/1998 | WO1998012176A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 03/26/1998 | WO1998011909A1 Use of proteins as agents against autoimmune diseases |
| 03/26/1998 | CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 03/26/1998 | CA2266639A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 03/26/1998 | CA2266346A1 Use of proteins as agents against autoimmune diseases |
| 03/26/1998 | CA2215856A1 Dihydrobenzofluorene compounds, intermediates, compositions, and methods |
| 03/26/1998 | CA2214935A1 Benzofluorene compounds, intermediates, compositions, and methods |
| 03/26/1998 | CA2214931A1 Tetrahydrobenzo-a-fluorene compounds and method of use |
| 03/26/1998 | CA2214929A1 Naphthofluorene compounds, intermediates, compositions and methods |
| 03/26/1998 | CA2214196A1 Benzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods |
| 03/26/1998 | CA2214176A1 Dihydrobenzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods |
| 03/25/1998 | EP0831089A1 Benzothiophene compounds, intermediates, processes, compositions, and methods |
| 03/25/1998 | EP0830374A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/25/1998 | EP0830138A1 Use of fibroblast growth factors to stimulate bone growth |
| 03/25/1998 | CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine |
| 03/25/1998 | CN1176813A Medicine for treating cervical spondylopathy |
| 03/24/1998 | US5731441 Hydroxamic acid derivatives with tricyclic substitution |
| 03/24/1998 | US5731436 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents |
| 03/24/1998 | US5731299 Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| 03/24/1998 | CA2214919A1 Benzothiophene compounds, intermediates, processes, compositions, and methods |
| 03/19/1998 | WO1998011223A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr) |
| 03/19/1998 | WO1998011128A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 03/19/1998 | WO1998011119A1 Novel pyranoside derivatives |
| 03/19/1998 | WO1998011089A1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors |
| 03/19/1998 | WO1998011062A1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect |
| 03/19/1998 | WO1998011049A1 Lipoxin compounds and their use in treating cell proliferative disorders |
| 03/19/1998 | WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 03/19/1998 | DE19637123A1 Neue Pyranosidderivate New Pyranosidderivate |